Riboflavin based setup as an alternative method for a preliminary screening of face mask filtration efficiency.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 04 2024
Historique:
received: 22 01 2024
accepted: 11 04 2024
medline: 19 4 2024
pubmed: 18 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

Face masks are essential in reducing the transmission of respiratory infections and bacterial filtration efficiency, a key parameter of mask performances, requires the use of Staphylococcus aureus and specialised staff. This study aims to develop a novel method for a preliminary screening of masks or materials filtration efficiency by a green, easy and rapid setup based on the use of a riboflavin solution, a safe autofluorescent biomolecule. The proposed setup is composed of a commercial aerosol generator commonly used for aerosol therapy, custom 3D printed aerosol chamber and sample holder, a filter for downstream riboflavin detection and a vacuum pump. The filtration efficiency of four different masks was assessed using the riboflavin-based setup and the bacterial filtration efficiency (BFE). The averaged filtration efficiency values, measured with both methods, were similar but were higher for the riboflavin-based setup (about 2% for all tested samples) than bacterial filtration efficiency. Considering the good correlation, the riboflavin-based setup can be considered validated as an alternative method to bacterial filtration efficiency for masks and related materials fabrics filtration efficiency screening but This study aims to develop a novel method for a preliminary screening of masks or materials filtration efficiency by a green, easy and rapid setup based on the use of a riboflavin solution, a safe autofluorescent biomolecule, but not to replace regulation approaches. The proposed setup can be easily implemented at low price, is more rapid and eco-friendly and can be performed in chemical-physical laboratories without the needing of biosafety laboratory and specialised operators.

Identifiants

pubmed: 38632265
doi: 10.1038/s41598-024-59485-7
pii: 10.1038/s41598-024-59485-7
pmc: PMC11024099
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8830

Informations de copyright

© 2024. The Author(s).

Références

Int J Environ Res Public Health. 2022 Mar 16;19(6):
pubmed: 35329234
Sci Rep. 2023 May 2;13(1):7115
pubmed: 37130944
Lancet. 2021 May 1;397(10285):1603-1605
pubmed: 33865497
ACS Nano. 2021 Apr 27;15(4):5904-5924
pubmed: 33822580
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857-14863
pubmed: 32527856
Intern Emerg Med. 2023 Jan;18(1):275-296
pubmed: 36103082
Anal Chim Acta. 2021 Feb 1;1144:1-13
pubmed: 33453785
Ann Occup Hyg. 1997 Dec;41(6):677-90
pubmed: 9375526
J Occup Environ Hyg. 2021 Mar;18(3):128-138
pubmed: 33476218
Sci Total Environ. 2020 Aug 20;731:139178
pubmed: 32388162
Am J Infect Control. 2021 Jan;49(1):1-7
pubmed: 33166599
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 5;246:119004
pubmed: 33070014
Environ Res. 2020 Sep;188:109819
pubmed: 32569870
Sep Purif Technol. 2022 Oct 1;298:121565
pubmed: 35765307
Sep Purif Technol. 2020 Nov 1;250:116886
pubmed: 32322159
Sci Rep. 2023 Dec 9;13(1):21807
pubmed: 38071253
Extreme Mech Lett. 2020 Oct;40:100924
pubmed: 32835043
IEEE Trans Instrum Meas. 2023;72:1-12
pubmed: 37323850
Heliyon. 2023 Dec 03;10(1):e23196
pubmed: 38163242
Sci Rep. 2021 Mar 15;11(1):5887
pubmed: 33723303
Nano Lett. 2021 Jan 13;21(1):651-657
pubmed: 33283521
Sci Rep. 2022 Jan 24;12(1):1188
pubmed: 35075199

Auteurs

Aida Cavallo (A)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Tamer Al Kayal (T)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Giorgio Soldani (G)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Paola Losi (P)

Institute of Clinical Physiology, National Research Council, Pisa, Italy. paola.losi@cnr.it.

Lorena Tedeschi (L)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH